Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23 | -$27 | -$29 | -$5 |
| Dep. & Amort. | $2 | -$3 | $2 | $2 |
| Deferred Tax | -$6 | -$8 | -$8 | -$2 |
| Stock-Based Comp. | $2 | $2 | $3 | $0 |
| Change in WC | -$8 | $15 | -$2 | $1 |
| Other Non-Cash | $1 | $5 | $1 | $2 |
| Operating Cash Flow | -$32 | -$15 | -$33 | -$2 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14 | -$53 | -$43 | -$92 |
| Inv. Sales/Matur. | $36 | $38 | $88 | $97 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $21 | -$15 | $44 | $4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$1 | $0 |
| Financing Cash Flow | -$1 | -$0 | -$1 | -$0 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$11 | -$31 | $9 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81 | $112 | $103 | $100 |
| End Cash | $70 | $81 | $112 | $102 |
| Free Cash Flow | -$32 | -$16 | -$34 | -$2 |